scholarly article | Q13442814 |
P50 | author | Lyle L Moldawer | Q92147747 |
Philip Efron | Q114427345 | ||
Alicia M Mohr | Q58928002 | ||
Shawn Larson | Q58928054 | ||
Tyler J. Loftus | Q40367397 | ||
P2093 | author name string | Frederick A Moore | |
Juan C Mira | |||
Julie A Stortz | |||
Steven L Raymond | |||
David C Holden | |||
P2860 | cites work | Lipoproteins take their toll on the host | Q73294953 |
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment | Q73400029 | ||
Plasma DNA as a prognostic marker in trauma patients | Q73510305 | ||
Enhanced expression of heat shock proteins in leukocytes from trauma patients | Q73570342 | ||
HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine | Q73606601 | ||
HMG-1 as a mediator of acute lung inflammation | Q74279708 | ||
Plasma mitochondrial DNA concentrations after trauma | Q75227896 | ||
Unresponsiveness of MyD88-deficient mice to endotoxin | Q78093558 | ||
Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production | Q79223858 | ||
High-mobility group box 1 protein plasma concentrations during septic shock | Q80382916 | ||
Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock | Q80518693 | ||
Extracellular hsp70 levels in children with septic shock | Q81693837 | ||
NLR-containing inflammasomes: central mediators of host defense and inflammation | Q83123252 | ||
Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury | Q83517390 | ||
Level I versus Level II trauma centers: an outcomes-based assessment | Q83801265 | ||
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ | Q84969853 | ||
The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life | Q85235656 | ||
S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons | Q44928282 | ||
Hsp70 release from peripheral blood mononuclear cells. | Q45098360 | ||
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. | Q45710766 | ||
Serum levels of Hsp 72 measured early after trauma correlate with survival | Q46479365 | ||
Relationship between American College of Surgeons trauma center designation and mortality in patients with severe trauma (injury severity score > 15). | Q46564103 | ||
Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock | Q46638317 | ||
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group | Q46886444 | ||
Effects of HSP70.1/3 gene knockout on acute respiratory distress syndrome and the inflammatory response following sepsis | Q47672801 | ||
Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury | Q47689828 | ||
Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. | Q48367562 | ||
Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. | Q48771529 | ||
GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. | Q49090833 | ||
Essential role of MD-2 in LPS responsiveness and TLR4 distribution. | Q50109313 | ||
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. | Q51132705 | ||
Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. | Q51998429 | ||
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. | Q53089518 | ||
Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. | Q53602874 | ||
Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. | Q54254423 | ||
Drotrecogin alfa (activated) in adults with septic shock. | Q55056165 | ||
Interferon-γ and Granulocyte-Macrophage Colony Stimulating Factor Therapy in Three Patients with Pulmonary Aspergillosis | Q57997454 | ||
Human CD8+ T cells and NK cells express and secrete S100B upon stimulation | Q59419271 | ||
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock* | Q60692890 | ||
Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis | Q63359105 | ||
A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients | Q67752780 | ||
Germs | Q70431267 | ||
Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial | Q72766272 | ||
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 | ||
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 | ||
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
Novel role of PKR in inflammasome activation and HMGB1 release | Q24293509 | ||
Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice | Q24329114 | ||
Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2 | Q24338327 | ||
Recognition of single-stranded RNA viruses by Toll-like receptor 7 | Q24568101 | ||
HMGB1: endogenous danger signaling | Q24645232 | ||
The coagulopathy of acute sepsis | Q26826950 | ||
Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity | Q27485306 | ||
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 | Q27860854 | ||
Neutrophil extracellular traps kill bacteria | Q27860996 | ||
HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators | Q28141330 | ||
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product | Q28141458 | ||
S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4 | Q28240188 | ||
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock | Q28244377 | ||
Approaching the asymptote? Evolution and revolution in immunology | Q28274344 | ||
High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 | ||
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group | Q28288504 | ||
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group | Q28302709 | ||
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Q28345147 | ||
Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA | Q28504793 | ||
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta | Q28506630 | ||
Mincle is an ITAM-coupled activating receptor that senses damaged cells | Q28506757 | ||
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components | Q28511151 | ||
The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors | Q28511605 | ||
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA | Q28513215 | ||
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells | Q28570659 | ||
Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins | Q28586768 | ||
Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury | Q37004607 | ||
RNA recognition via TLR7 and TLR8. | Q37028825 | ||
The origin and properties of extracellular DNA: from PAMP to DAMP. | Q37047827 | ||
Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. | Q37262438 | ||
Use of defined TLR ligands as adjuvants within human vaccines. | Q37825528 | ||
Endothelium--role in regulation of coagulation and inflammation | Q37918456 | ||
CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. | Q38316638 | ||
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial | Q38316900 | ||
Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome | Q38820842 | ||
Why have clinical trials in sepsis failed? | Q39242451 | ||
S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner. | Q39520634 | ||
Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis | Q39522724 | ||
SARM inhibits both TRIF- and MyD88-mediated AP-1 activation. | Q39725027 | ||
Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials | Q39908347 | ||
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. | Q40235280 | ||
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. | Q40249835 | ||
Regulation of monocyte migration by amphoterin (HMGB1). | Q40558415 | ||
The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo | Q40576654 | ||
The effect of early goal-directed therapy on mortality in patients with severe sepsis and septic shock: a meta-analysis | Q40657961 | ||
Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. | Q40751982 | ||
Plasma Nuclear and Mitochondrial DNA Levels, and Markers of Inflammation, Shock, and Organ Damage in Patients with Septic Shock | Q40851760 | ||
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study | Q41719170 | ||
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Q43565214 | ||
Activation of coagulation after administration of tumor necrosis factor to normal subjects | Q43690695 | ||
Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock | Q43776187 | ||
Enhanced expression of heat shock proteins in activated polymorphonuclear leukocytes in patients with sepsis | Q43820469 | ||
Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. | Q44116594 | ||
GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study | Q44243932 | ||
Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection | Q28587620 | ||
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2 | Q28646106 | ||
Tolerance, danger, and the extended family | Q29547532 | ||
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity | Q29547722 | ||
Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation | Q29617064 | ||
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response | Q29620414 | ||
Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants | Q30300455 | ||
Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion | Q33612700 | ||
The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation | Q33853348 | ||
Human macrophage activation programs induced by bacterial pathogens | Q34009967 | ||
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis | Q34127950 | ||
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death | Q34455153 | ||
The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. | Q34457606 | ||
Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis | Q34468940 | ||
A national evaluation of the effect of trauma-center care on mortality | Q34488161 | ||
Role of lipoteichoic acid in infection and inflammation | Q34522334 | ||
Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages | Q34847755 | ||
Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins | Q35025079 | ||
Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: unique roles for MD-2. | Q35049647 | ||
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock | Q35052743 | ||
The role of heat shock protein 70 in mediating age-dependent mortality in sepsis | Q35077846 | ||
Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency | Q35090141 | ||
Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency | Q35578631 | ||
Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing | Q35895741 | ||
Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis | Q36013740 | ||
Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room | Q36232049 | ||
The future of murine sepsis and trauma research models | Q36322341 | ||
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells | Q36371359 | ||
Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14. | Q36380685 | ||
Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates | Q36510003 | ||
Patterns of gene expression among murine models of hemorrhagic shock/trauma and sepsis | Q36510622 | ||
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial | Q36806209 | ||
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury | Q36933470 | ||
The inflammasome: a danger sensing complex triggering innate immunity | Q36989115 | ||
Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care | Q36995660 | ||
P433 | issue | 10 Pt B | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 2564-2573 | |
P577 | publication date | 2017-01-20 | |
P1433 | published in | BBA: Molecular Basis of Disease | Q15749547 |
P1476 | title | Microbial recognition and danger signals in sepsis and trauma | |
P478 | volume | 1863 |
Q58564826 | Alcohol Binge Reduces Systemic Leukocyte Activation and Pulmonary PMN Infiltration After Blunt Chest Trauma and Hemorrhagic Shock |
Q47350221 | Amyloid-Like β-Aggregates as Force-Sensitive Switches in Fungal Biofilms and Infections. |
Q92316228 | Antibiotic-Resistant Septicemia in Pediatric Oncology Patients Associated with Post-Therapeutic Neutropenic Fever |
Q52676917 | Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: Set the bugs to work? |
Q47096645 | Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? |
Q90197469 | Cell-free nuclear, but not mitochondrial, DNA concentrations correlate with the early host inflammatory response after severe trauma |
Q90259238 | Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome |
Q90707412 | Damage-associated molecular patterns in trauma |
Q50002873 | Danger Signals in the ICU. |
Q88801933 | Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis |
Q55355541 | Danger signals in trauma. |
Q64106140 | Development and validation of a novel predictive score for sepsis risk among trauma patients |
Q64058880 | Discovery of 2-Substituted 3-Arylquinoline Derivatives as Potential Anti-Inflammatory Agents Through Inhibition of LPS-Induced Inflammatory Responses in Macrophages |
Q92991053 | Early Local Inhibition of Club Cell Protein 16 Following Chest Trauma Reduces Late Sepsis-Induced Acute Lung Injury |
Q88851045 | Immune and metabolic alterations following trauma and sepsis - An overview |
Q37627158 | Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches. |
Q50324081 | Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults. |
Q38660625 | Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease. |
Q88451231 | Long-Term Cognitive Outcomes After Sepsis: a Translational Systematic Review |
Q47791665 | Mitochondrial dysfunction in rat splenocytes following hemorrhagic shock |
Q40066414 | Neutrophil chemotaxis and transcriptomics in term and preterm neonates |
Q58735789 | Optimizing transfusion strategies in damage control resuscitation: current insights |
Q51737047 | Preterm Life in Sterile Conditions: A Study on Preterm, Germ-Free Piglets. |
Q90403945 | Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients |
Q45873366 | Simoctocog alfa for the treatment of hemophilia A. |
Q64067986 | TLR3 Ligand PolyI:C Prevents Acute Pancreatitis Through the Interferon-β/Interferon-α/β Receptor Signaling Pathway in a Caerulein-Induced Pancreatitis Mouse Model |
Q38769811 | The Role of IFN-β during the Course of Sepsis Progression and Its Therapeutic Potential. |
Search more.